• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓系恶性肿瘤中基因组和RNA剪接特征的多模态分析

A multimodal analysis of genomic and RNA splicing features in myeloid malignancies.

作者信息

Durmaz Arda, Gurnari Carmelo, Hershberger Courtney E, Pagliuca Simona, Daniels Noah, Awada Hassan, Awada Hussein, Adema Vera, Mori Minako, Ponvilawan Ben, Kubota Yasuo, Kewan Tariq, Bahaj Waled S, Barnard John, Scott Jacob, Padgett Richard A, Haferlach Torsten, Maciejewski Jaroslaw P, Visconte Valeria

机构信息

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Systems Biology and Bioinformatics Department, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.

出版信息

iScience. 2023 Feb 18;26(3):106238. doi: 10.1016/j.isci.2023.106238. eCollection 2023 Mar 17.

DOI:10.1016/j.isci.2023.106238
PMID:36926651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10011742/
Abstract

RNA splicing dysfunctions are more widespread than what is believed by only estimating the effects resulting by splicing factor mutations (SF) in myeloid neoplasia (MN). The genetic complexity of MN is amenable to machine learning (ML) strategies. We applied an integrative ML approach to identify co-varying features by combining genomic lesions (mutations, deletions, and copy number), exon-inclusion ratio as measure of RNA splicing (percent spliced in, PSI), and gene expression (GE) of 1,258 MN and 63 normal controls. We identified 15 clusters based on mutations, GE, and PSI. Different PSI levels were present at various extents regardless of SF suggesting that changes in RNA splicing were not strictly related to SF. Combination of PSI and GE further distinguished the features and identified PSI similarities and differences, common pathways, and expression signatures across clusters. Thus, multimodal features can resolve the complex architecture of MN and help identifying convergent molecular and transcriptomic pathways amenable to therapies.

摘要

RNA剪接功能障碍比仅通过估计髓系肿瘤(MN)中剪接因子突变(SF)所产生的影响所认为的更为普遍。MN的遗传复杂性适合采用机器学习(ML)策略。我们应用了一种综合ML方法,通过结合1258例MN和63例正常对照的基因组损伤(突变、缺失和拷贝数)、作为RNA剪接指标的外显子包含率(剪接百分率,PSI)以及基因表达(GE)来识别共同变化的特征。我们基于突变、GE和PSI识别出了15个簇。无论SF如何,不同程度上都存在不同的PSI水平,这表明RNA剪接的变化与SF并不严格相关。PSI和GE的组合进一步区分了特征,并识别出了各簇之间的PSI异同、共同途径和表达特征。因此,多模态特征可以解析MN的复杂结构,并有助于识别适合治疗的趋同分子和转录组途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/dee5378fb021/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/804dacc1a099/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/6cd6545e4245/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/9ae61d86a0b6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/942959d9cc23/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/994185c5e009/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/dee5378fb021/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/804dacc1a099/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/6cd6545e4245/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/9ae61d86a0b6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/942959d9cc23/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/994185c5e009/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c2/10011742/dee5378fb021/gr5.jpg

相似文献

1
A multimodal analysis of genomic and RNA splicing features in myeloid malignancies.髓系恶性肿瘤中基因组和RNA剪接特征的多模态分析
iScience. 2023 Feb 18;26(3):106238. doi: 10.1016/j.isci.2023.106238. eCollection 2023 Mar 17.
2
Alternative Splicing Signatures in RNA-seq Data: Percent Spliced in (PSI).RNA测序数据中的可变剪接特征:剪接百分率(PSI)
Curr Protoc Hum Genet. 2015 Oct 6;87:11.16.1-11.16.14. doi: 10.1002/0471142905.hg1116s87.
3
Characterization of alternative splicing events and prognostic signatures in breast cancer.乳腺癌中可变剪接事件和预后特征的分析。
BMC Cancer. 2021 May 22;21(1):587. doi: 10.1186/s12885-021-08305-6.
4
Complex landscape of alternative splicing in myeloid neoplasms.髓系肿瘤中可变剪接的复杂景观。
Leukemia. 2021 Apr;35(4):1108-1120. doi: 10.1038/s41375-020-1002-y. Epub 2020 Aug 4.
5
Integrating many co-splicing networks to reconstruct splicing regulatory modules.整合多个共剪接网络以重建剪接调控模块。
BMC Syst Biol. 2012;6 Suppl 1(Suppl 1):S17. doi: 10.1186/1752-0509-6-S1-S17. Epub 2012 Jul 16.
6
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes.剪接因子突变在骨髓增生异常综合征中的独特和趋同后果。
Am J Hematol. 2020 Feb;95(2):133-143. doi: 10.1002/ajh.25673. Epub 2019 Nov 18.
7
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer.剪接模式揭示肌层浸润性膀胱癌的预后指标。
World J Surg Oncol. 2022 Jul 12;20(1):231. doi: 10.1186/s12957-022-02685-0.
8
CAGI experiments: Modeling sequence variant impact on gene splicing using predictions from computational tools.CAGI 实验:使用计算工具的预测模型来模拟序列变异对基因剪接的影响。
Hum Mutat. 2019 Sep;40(9):1252-1260. doi: 10.1002/humu.23782. Epub 2019 Jun 27.
9
Identification of prognostic alternative splicing signature in gastric cancer.胃癌中预后性可变剪接特征的鉴定
Arch Public Health. 2022 May 25;80(1):145. doi: 10.1186/s13690-022-00894-3.
10
Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.结直肠癌中可变剪接的特征及其临床意义:基于大规模测序数据的研究。
EBioMedicine. 2018 Oct;36:183-195. doi: 10.1016/j.ebiom.2018.09.021. Epub 2018 Sep 19.

引用本文的文献

1
RNA binding protein-directed control of leukemic stem cell evolution and function.RNA结合蛋白对白血病干细胞进化和功能的定向调控。
Hemasphere. 2024 Aug 22;8(8):e116. doi: 10.1002/hem3.116. eCollection 2024 Aug.
2
The Heterogeneous Complexity of Myeloid Neoplasm: Multi-Level Approaches to Study the Disease.髓系肿瘤的异质性复杂性:研究该疾病的多层次方法
Cancers (Basel). 2023 Feb 24;15(5):1449. doi: 10.3390/cancers15051449.

本文引用的文献

1
Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond.个体 HLA 异质性及其对癌症及其他疾病中细胞免疫逃逸的影响。
Front Immunol. 2022 Sep 5;13:944872. doi: 10.3389/fimmu.2022.944872. eCollection 2022.
2
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.一种用于理解急性髓系白血病异质性和预测药物反应的细胞层次结构框架。
Nat Med. 2022 Jun;28(6):1212-1223. doi: 10.1038/s41591-022-01819-x. Epub 2022 May 26.
3
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q.
5q 缺失导致的分子谱的病理生理和临床意义。
EBioMedicine. 2022 Jun;80:104059. doi: 10.1016/j.ebiom.2022.104059. Epub 2022 May 23.
4
The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence.血液学研究的未来:将常规研究与真实世界数据和人工智能相结合。
Blood Rev. 2022 Jul;54:100914. doi: 10.1016/j.blre.2021.100914. Epub 2021 Dec 18.
5
Have we reached a molecular era in myelodysplastic syndromes?我们是否已经进入骨髓增生异常综合征的分子时代?
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):418-427. doi: 10.1182/hematology.2021000276.
6
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes.TET2 突变作为骨髓增生异常综合征中 DNA 双加氧酶缺乏的一部分。
Blood Adv. 2022 Jan 11;6(1):100-107. doi: 10.1182/bloodadvances.2021005418.
7
Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS.机器学习分析骨髓组织病理学鉴别 MDS 患者的遗传和临床决定因素
Blood Cancer Discov. 2021 Mar 22;2(3):238-249. doi: 10.1158/2643-3230.BCD-20-0162. eCollection 2021 May.
8
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes.一种用于骨髓增生异常综合征诊断的基因-临床决策模型。
Blood Adv. 2021 Nov 9;5(21):4361-4369. doi: 10.1182/bloodadvances.2021004755.
9
How artificial intelligence might disrupt diagnostics in hematology in the near future.人工智能在不远的将来可能如何颠覆血液学诊断
Oncogene. 2021 Jun;40(25):4271-4280. doi: 10.1038/s41388-021-01861-y. Epub 2021 Jun 8.
10
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia.机器学习整合基因组特征,可实现急性髓系白血病的主次分类之外的亚分类。
Blood. 2021 Nov 11;138(19):1885-1895. doi: 10.1182/blood.2020010603.